Mildly Dilated Cardiomyopathy

  • M. Porcu
  • R. De Maria
  • A. Gavazzi
  • Italian Study Group on Cardiomyopathies (SPIC)
Conference paper


Dilated cardiomyopathy is considered a disease of uncertain and probably heterogeneous origin, characterized by dilatation and impaired systolic function of the left or both ventricles [1]. Although this definition underscores the typical pathological aspect of dilated cardiomyopathy, there is increasing evidence that a larger spectrum of morphological conditions can be included in this unexplained heart muscle disease. In fact, patients with impairment of systolic function of unknown cause show a wide range of left ventricular dimensions, from very enlarged to absolutely normal chambers [2]. In the past, different studies attributed a prognostic significance to the degree of left ventricular dilatation, that was considered as one of the factors predicting mortality in patients with dilated cardiomyopathy [3–6]. However, other observations on small series have recently shown that patients with an idiopathic reduction of contractility may have an unfavorable outcome despite the absence of relevant left ventricular enlargement [7,8]. Moreover, a preliminary analysis of 144 patients enrolled in the SPIC (Italian Multicentric Study on Cardiomyopathies) Registry and followed up for about three years did not confirm the role of ventricular dilatation as an independent negative prognostic factor [9].


Dilate Cardiomyopathy Left Bundle Branch Block Idiopathic Dilate Cardiomyopathy Left Ventricular Dilatation Left Ventricular Dimension 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Report of the 1995 World Health Organization /International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies (1996) Circulation 93:841–842CrossRefGoogle Scholar
  2. 2.
    Gavazzi A, De Maria R, Porcu, Beretta L, Casazza F, Castelli G, Luvini M, Parodi O, Recalcati F, Renosto G, Sinagra G, De Vita C, Camerini F, Baroldi G (1995) Cardiomiopatia dilatativa: una nuova storia naturale? L’esperienza dello Studio Italiano Policentrico Cardiomiopatie (SPIC). G Ital Cardiol 25:1109–1125PubMedGoogle Scholar
  3. 3.
    Komajda M, Jaist JP, Reeves F, Goldfarb B, Bouthour JB, Juillieres Y, Lanfranchi J, Peycelon P, Geslin PH, Carriett D, Grosgogeat Y (1990) Factors predicting mortality in idiopathic dilated cardiomyopaty. Eur Heart J 11:824–831PubMedGoogle Scholar
  4. 4.
    Diaz RA, Obasohan A, Oakley CM (1987) Prediction of outcome in dilated cardiomyopathy. Br Heart J 58:393–399PubMedCrossRefGoogle Scholar
  5. 5.
    Gavazzi A, Lanzarini L, Cornalba C, Desperati M, Raisaro A, Angoli L, De Servi S, Specchia G (1984) Dilated (congestive) cardiomyopathy. Follow-up study of 137 patients. G Ital Cardiol 11:492–498Google Scholar
  6. 6.
    Di Lenarda A, Secoli G, Perkan A, Gregori D, Lardieri G, Pinamonti B, Sinagra G, Zecchin M, Camerini F and the Heart Muscle Disease Study Group (1994) Changing mortality in dilated cardiomyopathy. Br Heart J 72 [Suppl]:S46–S51PubMedCrossRefGoogle Scholar
  7. 7.
    Keren A, Billingham ME, Weintraub D, Stinson EB, Popp RL (1985) Mildly dilated congestive cardiomyopathy. Circulation 72:302–309PubMedCrossRefGoogle Scholar
  8. 8.
    Keren A, Gottlieb S, Tzivoni D, Yarom R, Billingham ME, Popp RL (1990) Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation 81:506–517Google Scholar
  9. 9.
    Gavazzi A, De Maria R, Renosto G, Moro A, Borgia M, Caroli A, Castelli G, Ciaccheri M, Pavan D, De Vita C, Baroldi G, Camerini F (1993) on behalf of the SPIC Group: The spectrum of left ventricular size in dilated cardiomyopathy: clinical correlates and prognostic implications. Am Heart J 125:410–422PubMedCrossRefGoogle Scholar
  10. 10.
    Sahn DJ, De Maria AN, Kisslo J, Weyman A, (1976) The committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 58:1072–1083Google Scholar
  11. 11.
    Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EGJ, Schoen FJ (1986) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14Google Scholar
  12. 12.
    Hinkle L, Thaler J (1982) Clinical classification of cardiac deaths. Circulation 65:457–464PubMedCrossRefGoogle Scholar
  13. 13.
    Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 23:1564–1575CrossRefGoogle Scholar
  14. 14.
    Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264:377–38PubMedCrossRefGoogle Scholar
  15. 15.
    Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320:409–415PubMedCrossRefGoogle Scholar
  16. 16.
    Prazak P, Pfisterer M, Osswald S, Buser P, Burkart F (1996) Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy. Eur Heart J 17:251–257PubMedCrossRefGoogle Scholar
  17. 17.
    De Maria R, Gavazzi A, Caroli A, Ometto R, Biagini A, Camerini F (1992) Ventricular arrhythmias in dilated cardiomyopathy as an independent prognostic hallmark. Am J Cardiol 69:1451–1457PubMedCrossRefGoogle Scholar
  18. 18.
    Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60:1340–1355PubMedCrossRefGoogle Scholar
  19. 19.
    Fuster V, Gersh BJ Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47:525–531PubMedCrossRefGoogle Scholar
  20. 20.
    Ikram H, Williamson HG, Won IG, Wells EJ (1987) The course of idiopathic dilated cardiomyopathy in New Zealand. Br Heart J 57:521–517PubMedCrossRefGoogle Scholar
  21. 21.
    Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H (1988) Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants. Am Heart J 116:1455–146PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • M. Porcu
  • R. De Maria
  • A. Gavazzi
  • Italian Study Group on Cardiomyopathies (SPIC)

There are no affiliations available

Personalised recommendations